Log in to your Inderes Free account to see all free content on this page.

Aker BioMarine

Less than 1K followers

AKBM

Oslo Børs

Food Producers

Consumer Goods & Services

Overview

Ownership

Investor consensus

Aker BioMarine operates in biotechnology. The company specializes in the development of dietary supplements. The product portfolio is broad and includes, for example, omega-3 oil, nutritional supplements for animals, and protein supplements for fish farming. The business is operated globally with the largest presence in the Nordic market. Customers consist of both private players and wholesalers. Aker BioMarine was founded in 2006 and is headquartered in Oslo.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

All

Press releases

ShowingAll content types

Regulatory press release11/5/2025, 1:52 PM

AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

Regulatory press release11/5/2025, 8:50 AM

AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

Regulatory press release10/31/2025, 6:00 AM

AKBM: Third quarter 2025 results for Aker BioMarine

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release10/28/2025, 4:34 PM

Aker BioMarine ASA - Invitation to presentation of the third quarter 2025 results

Regulatory press release9/1/2025, 5:00 AM

AKBM: Aker BioMarine wins new business for Superba Krill Oil

Regulatory press release7/18/2025, 12:55 PM

AKBM: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

Regulatory press release7/11/2025, 5:00 AM

AKBM: Second quarter 2025 results for Aker BioMarine

Regulatory press release6/20/2025, 2:48 PM

Euronext Oslo Børs - Aker BioMarine ASA - Received application for listing of bonds

Regulatory press release6/16/2025, 12:00 PM

Aker BioMarine ASA - Base prospectus approved for listing of bonds

Regulatory press release5/2/2025, 12:45 PM

AKBM: Mandatory notification of trade

Regulatory press release4/30/2025, 5:00 AM

AKBM: First quarter 2025 results for Aker BioMarine

Regulatory press release4/28/2025, 4:00 PM

Aker BioMarine ASA - Invitation to presentation of the first quarter 2025 results

Regulatory press release4/26/2025, 7:05 AM

Aker BioMarine ASA - Minutes of Annual General Meeting

Regulatory press release4/2/2025, 6:15 AM

Aker BioMarine ASA - Notice of Annual General Meeting (Correction)

Regulatory press release3/31/2025, 6:00 AM

Aker BioMarine ASA - Annual Report 2024

Regulatory press release3/31/2025, 6:00 AM

Aker BioMarine ASA - Notice of Annual General Meeting

Regulatory press release3/4/2025, 8:28 AM

Aker BioMarine ASA - Registration of share capital increase

Regulatory press release3/3/2025, 8:53 PM

Aker BioMarine ASA - Registration of share capital increase

Regulatory press release2/22/2025, 8:54 AM

Aker BioMarine ASA - Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program

Regulatory press release2/22/2025, 7:32 AM

AKBM - Offer under Employee Share Purchase Program and share capital increase

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.